ATCC announces award from national institute of allergy and infectious diseases to support its preclinical services for biopharmaceutical product development Post author: Post published:November 13, 2023 Post category:uncategorized ATCC today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract. You Might Also Like Insufficient sleep during pregnancy associated with neurodevelopmental risks in offspring September 26, 2024 Tiny protein region unlocks secrets to healthy heartbeat February 26, 2026 RNA Therapies in Liver Disease: Insights from Ochre Bio’s CEO January 24, 2024
Insufficient sleep during pregnancy associated with neurodevelopmental risks in offspring September 26, 2024